Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent. - Wikidata - awgldk - TriplyDB

Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent.

Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent.

http://www.wikidata.org/entity/Q30010641

about

Metabolic disposition of the anti-cancer agent [(14)C]laromustine in male rats RRx-001, A novel dinitroazetidine radiosensitizer NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001 RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials.Development of methods for the bioanalysis of RRx-001 and metabolites.Real time dynamic imaging and current targeted therapies in the war on cancer: a new paradigm Impact of hemoglobin nitrite to nitric oxide reductase on blood transfusion for resuscitation from hemorrhagic shock From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial: A TITE-CRM Phase I/II Clinical Trial.A novel hypoxia-selective epigenetic agent RRx-001 triggers apoptosis and overcomes drug resistance in multiple myeloma cells.The implications of hyponitroxia in cancer.Epigenetic effects of RRx-001: a possible unifying mechanism of anticancer activity.The macrophage stimulating anti-cancer agent, RRx-001, protects against ischemia-reperfusion injury.Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001 Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generation.Site of reactivity models predict molecular reactivity of diverse chemicals with glutathione.Two Case Reports of Resensitization to Previous Chemotherapy with the Novel Hypoxia-Activated Hypomethylating Anticancer Agent RRx-001 in Metastatic Colorectal Cancer Patients.Magnetic resonance imaging of RRx-001 pharmacodynamics in preclinical tumors.A look inside the mechanistic black box: Are red blood cells the critical effectors of RRx-001 cytotoxicity?The dichotomous role of H2S in cancer cell biology? Déjà vu all over again.

P2860

Q23909637-8671D82A-5099-46E3-B5D5-B746E1E227A7 Q26769671-5E49DCFD-C23A-478D-8740-05843F247826 Q27003845-05C869F8-0129-45C2-A1F0-25EB1FC33B0B Q30010522-B2D12824-396A-406D-AC57-4E7C7F957908 Q30010599-933038C9-3DC5-4DC4-9D12-EE034DEE99B2 Q30453423-34DB1BCB-6FEC-404F-B390-1FFAE6F4DC1B Q35119905-082D9318-99D5-4460-A5CC-27BAC4161D6B Q35676444-FB816749-E07D-4A2B-89C1-6E8F37BDF644 Q36804495-3A642FAC-9033-4477-9416-E34025D02634 Q37389377-6A8CE93D-33FA-4D0C-B14A-50E65E7AF272 Q38204520-56650C38-03DC-4F28-9D3F-F813C3842C12 Q38812418-83FAE120-0934-47BF-9BC0-37F2D44C1EFF Q38817294-5AC7744E-5358-4992-B0B1-73AE3ED29279 Q38843175-7267CBD6-8CB5-474A-BC20-CD64B7989EED Q39632862-856556DA-0ACD-42B4-A915-326D3A6FB9EB Q41289680-FEA04534-914D-4D34-B5CA-9D1D785DBCE4 Q41977838-14AF3B66-D73B-43A9-88F5-73865AC53AAE Q46237277-C408CC4A-24D9-4553-A027-C96BE05A82BA Q47960118-30A46A6A-53EA-4840-AEFE-67545155C482 Q49346285-F4B21219-762A-4E26-BDD3-F3F5BE172C1D

P2860

Preclinical evaluation of the metabolism and disposition of RRx-001, a novel investigative anticancer agent.

http://www.wikidata.org/entity/Q30010641

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Preclinical evaluation of the ...... nvestigative anticancer agent.

@ast

Preclinical evaluation of the ...... nvestigative anticancer agent.

@en

type

label

Preclinical evaluation of the ...... nvestigative anticancer agent.

@ast

Preclinical evaluation of the ...... nvestigative anticancer agent.

@en

prefLabel

Preclinical evaluation of the ...... nvestigative anticancer agent.

@ast

Preclinical evaluation of the ...... nvestigative anticancer agent.

@en

P1433

Q30010641-EC639E39-A3FE-4303-A444-3251FA5F21EF

P1476

Q30010641-0BB8963E-7AC8-472A-9E8F-8D71B938AEDF

P2093

Q30010641-131E49AC-57ED-4367-98D0-D60A79184B52

Q30010641-35FF2493-0C6F-4154-A40B-30AF598D2195

Q30010641-83B0A614-2242-4457-A9EE-221B3C825ADA

Q30010641-9AF9E400-1EA2-4B7B-9A7F-2F8772274EE7

Q30010641-9B74A480-0D6F-4CF6-B76E-275941FA6C16

Q30010641-CEE9DD1A-A493-4EE6-824E-50B1C24F8537

Q30010641-E7C4C241-E65E-49E2-9F72-4668163B48DF

Q30010641-F2B81BB6-294D-4CF1-9BC6-8C72DDB0566B

P304

Q30010641-88F1D7E3-821A-48C5-8185-5B18A2CDC6DA

P31

Q30010641-3A7D043E-6A90-450C-ACF4-80A610F25D0F

P3181

Q30010641-710E2E04-55B3-4ADA-8085-63874FA58FC1

P356

Q30010641-9A8911A5-C422-4AED-94A7-EC4F938BF8F5

P433

Q30010641-F6E2ED4A-90D0-4D46-BA0E-10432E43AEAC

P478

Q30010641-0070BA80-528D-4310-9973-7225162F7505

P577

Q30010641-87A9C16B-B27C-400A-AC1B-F90332BF4D76

P5875

Q30010641-4D8956F2-9874-468A-9AD5-829634FBEFA6

P698

Q30010641-BB884749-AB4D-4F18-9DD8-521A4FE1E908

P3181

P356

P1433

Drug Metabolism and Disposition

P1476

Preclinical evaluation of the ...... nvestigative anticancer agent.

@en

P2093

Bryan Oronsky

http://www.w3.org/2001/XMLSchema#string

Christopher M Adams

http://www.w3.org/2001/XMLSchema#string

Gang Luo

http://www.w3.org/2001/XMLSchema#string

Jan Scicinski

http://www.w3.org/2001/XMLSchema#string

Joseph Marini

http://www.w3.org/2001/XMLSchema#string

Michael Taylor

http://www.w3.org/2001/XMLSchema#string

Timothy Musick

http://www.w3.org/2001/XMLSchema#string

William L Fitch

http://www.w3.org/2001/XMLSchema#string

P304

1810-1816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4878726

http://www.w3.org/2001/XMLSchema#string

P356

10.1124/DMD.112.046755

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2012-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225374259

http://www.w3.org/2001/XMLSchema#string

P698

22699395

http://www.w3.org/2001/XMLSchema#string